Eagle Asset Management Inc Novartis Ag Transaction History

Eagle Asset Management Inc

  • $16.7 Billion
  • Q3 2024

A detailed history of Eagle Asset Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Eagle Asset Management Inc holds 11,267 shares of NVS stock, worth $1.11 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,267
Previous 11,425 1.38%
Holding current value
$1.11 Million
Previous $1.22 Million 6.5%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$106.13 - $120.89 $16,768 - $19,100
-158 Reduced 1.38%
11,267 $1.3 Million
Q2 2024

Aug 12, 2024
BUY
$92.57 - $107.37 $7,220 - $8,374
78 Added 0.69%
11,425 $1.22 Million
Q1 2024

May 09, 2024
SELL
$95.27 - $108.47 $34,868 - $39,700
-366 Reduced 3.12%
11,347 $1.1 Million
Q4 2023

Feb 12, 2024
SELL
$92.27 - $101.54 $51,025 - $56,151
-553 Reduced 4.51%
11,713 $1.18 Million
Q3 2023

Nov 13, 2023
SELL
$94.73 - $105.13 $34,102 - $37,846
-360 Reduced 2.85%
12,266 $1.25 Million
Q2 2023

Aug 09, 2023
BUY
$92.52 - $104.91 $307,906 - $349,140
3,328 Added 35.79%
12,626 $1.27 Million
Q1 2023

May 08, 2023
BUY
$80.03 - $92.81 $2,160 - $2,505
27 Added 0.29%
9,298 $855,000
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $14,883 - $18,226
-197 Reduced 2.08%
9,271 $841,000
Q3 2022

Nov 07, 2022
SELL
$74.61 - $87.26 $4,849 - $5,671
-65 Reduced 0.68%
9,468 $719,000
Q2 2022

Aug 10, 2022
SELL
$80.52 - $93.75 $52,257 - $60,843
-649 Reduced 6.37%
9,533 $805,000
Q1 2022

May 12, 2022
SELL
$80.11 - $90.62 $70,737 - $80,017
-883 Reduced 7.98%
10,182 $893,000
Q4 2021

Feb 11, 2022
SELL
$79.7 - $88.13 $239,578 - $264,918
-3,006 Reduced 21.36%
11,065 $967,000
Q3 2021

Nov 10, 2021
BUY
$81.78 - $95.14 $96,909 - $112,740
1,185 Added 9.2%
14,071 $1.15 Million
Q2 2021

Aug 11, 2021
BUY
$85.24 - $94.15 $63,589 - $70,235
746 Added 6.14%
12,886 $1.18 Million
Q1 2021

May 14, 2021
BUY
$83.5 - $98.47 $618,651 - $729,564
7,409 Added 156.61%
12,140 $1.05 Million
Q4 2020

Feb 12, 2021
SELL
$78.07 - $94.43 $665,156 - $804,543
-8,520 Reduced 64.3%
4,731 $446,000
Q3 2020

Nov 12, 2020
SELL
$82.14 - $91.0 $48,955 - $54,236
-596 Reduced 4.3%
13,251 $1.15 Million
Q2 2020

Aug 12, 2020
SELL
$80.93 - $91.1 $8,416 - $9,474
-104 Reduced 0.75%
13,847 $1.21 Million
Q1 2020

May 11, 2020
SELL
$70.67 - $99.01 $50,317 - $70,495
-712 Reduced 4.86%
13,951 $1.15 Million
Q4 2019

Feb 07, 2020
BUY
$84.35 - $95.37 $62,503 - $70,669
741 Added 5.32%
14,663 $1.39 Million
Q3 2019

Nov 04, 2019
SELL
$85.54 - $94.26 $101 Million - $111 Million
-1,177,456 Reduced 98.83%
13,922 $1.21 Million
Q2 2019

Aug 05, 2019
BUY
$75.4 - $92.8 $6.41 Million - $7.89 Million
84,989 Added 7.68%
1,191,378 $109 Million
Q1 2019

May 01, 2019
BUY
$75.32 - $86.15 $19.2 Million - $21.9 Million
254,448 Added 29.87%
1,106,389 $106 Million
Q4 2018

Feb 11, 2019
BUY
$73.66 - $82.02 $612,777 - $682,324
8,319 Added 0.99%
851,941 $73.1 Million
Q3 2018

Nov 08, 2018
BUY
$66.94 - $77.43 $55.5 Million - $64.2 Million
829,174 Added 5739.02%
843,622 $72.7 Million
Q2 2018

Aug 07, 2018
BUY
$64.91 - $73.36 $103,791 - $117,302
1,599 Added 12.44%
14,448 $1.09 Million
Q1 2018

May 09, 2018
BUY
$70.39 - $84.15 $151,549 - $181,174
2,153 Added 20.13%
12,849 $1.04 Million
Q4 2017

Feb 09, 2018
BUY
$72.33 - $77.64 $259,881 - $278,960
3,593 Added 50.58%
10,696 $913,000
Q3 2017

Nov 09, 2017
BUY
$74.14 - $77.27 $526,616 - $548,848
7,103
7,103 $613,000

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email